Medical Care / Autism Spectrum Disorder Market - Global Growth, Trends And Forecast (2022 - 2027) By Types, By Application, By Regions And By Key Players: Otsuka, AstraZeneca, Pfizer, Eli Lilly
Autism Spectrum Disorder Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Otsuka, AstraZeneca, Pfizer, Eli Lilly
Registering a CAGR of 10.5% over the forecast period of 2022-2027, the global Autism Spectrum Disorder market is anticipated to reach the market value of US$ 1.99 billion in the year 2027 from US$ 1.73 billion in the year 2021.
Autism Spectrum Disorder Market Overview
Autism spectrum disorder, also identified as ASD, refers to a collection of neurological disorders characterized by persistent deficits in social interaction and social communication and a repetitive/restricted pattern of behavior or activities. Autistic disorder, Asperger syndrome, and Pervasive Development Disorder (PDD) are the three main types of the disorder, which affect millions of people globally.
The report aspects discussed the profile of the top manufacturers of the global Autism Spectrum Disorder market. These aspects include the financial status of major companies, trending advancements and the entire market scenario. Growth of the report has examined Autism Spectrum Disorder Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.
Industry Updates:
30th January 2018, Roche’s balovaptan has picked up a Breakthrough Therapy Designation in the US for its potential as a treatment for people with autism spectrum disorder (ASD), potentially placing the drug on a faster path to market.
U.S. Food and Drug Administration authorized marketing of a device to help diagnose autism spectrum disorder (ASD). The Cognoa ASD Diagnosis Aid is a machine learning-based software intended to help health care providers diagnose ASD in children 18 months through 5 years of age who exhibit potential symptoms of the disorder.
What are the major Applications, Types and Regions for Autism Spectrum Disorder Market?
Autism Spectrum DisorderMarket is segmented based on the type, applications, companies and regions.
Market Volume (%) By Type, it is segmented into
Center-Based
In-Home
Others
Market Volume (%) By Applications it is segmented into
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-Oncology
Other
Autism Spectrum Disorder Market Regional Analysis
The North America market size stood at USD 1.12 billion in 2021. The increasing prevalence of autism disorder across the U.S., coupled with the rising adoption and uptake of therapies are attributable to the region’s dominance. For instance, according to the John Hopkins report published in 2020, the autism prevalence in the U.S. has been tripled since 2001 from 0.70 to 1.91%.
All these factors greatly affect the Autism Spectrum Disorder market growth. It further aims at providing complete overview on detailed assessment of significant features of different industries including sales value, sales volume, market revenue, and demand size, sales growth, pricing analysis and changing market growth factors in regions such as Follows,
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
Middle East & Africa
Latin America
The Autism Spectrum Disorder Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Autism Spectrum Disorder Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
What is our Autism Spectrum Disorder Market report scope?
The report includes in-depth assessment of the competitive landscape, product market sizing (Value and Volume), product benchmarking, market trends, product developments, financial analysis, strategic analysis and many more to measure the impact forces and potential opportunities of the market. As well as this the report also includes a study of major developments in the market like product launches, agreements, acquisitions, collaborations, mergers and many more to comprehend the prevailing market dynamics at current and its impact in the forecast period 2012-2027.
Report Attributes
Report Details
Forecast Period 2022 to 2027 CAGR (Value and Volume)
CAGR of 10.5% during the review period (2022 to 2027).
Market Volume (%) By Type(Revenue, USD Million, 2017 - 2022)
Center-Based
In-Home
Others
Market Volume (%) By Type(Revenue, USD Million, 2017 - 2022)
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-Oncology
Others
Quantitative units
Revenue in USD million/billion and CAGR from 2022 to 2027
By Companies
Otsuka, AstraZeneca, Pfizer, Eli Lilly, Johnson & Johnson, Roche
Regions Covered
North America
Europe
Asia-Pacific
Rest of the World
Countries Covered
US
Canada
Germany
France
UK
Italy
Spain
Rest of Europe
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
Latin America
Base Year
2022
Historical Year
2017 to 2021
Forecast Year
2022 to 2027
Customization Available
Yes, the report can be customized as per your needs
Key Highlights from this Autism Spectrum Disorder Report
A comprehensive backdrop analysis, which contains an assessment of the parent market
Essential changes in market dynamics.
Market segmentation up to the second or third level.
Historical, current, and projected size of the market from the standpoint of both value and volume.
Reporting and evaluation of recent industry developments.
Market shares and strategies of major players.
Emerging niche segments and regional markets.
An objective assessment of the trajectory of the market.
Recommendations to companies for strengthening their foothold in the market.
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
Frequently Asked Questions
What is the study period of this market?
The Autism Spectrum Disorder Market is studied from 2017 - 2027.
What is the growth rate of Autism Spectrum Disorder Market?
The Autism Spectrum Disorder Market is growing at a CAGR of 10.5% over the next 5 years.
Who are the key players in Autism Spectrum Disorder Market?
Otsuka, AstraZeneca, Pfizer, Eli Lilly, Johnson & Johnson, Roche
What region does this Autism Spectrum Disorder Market report covers?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Autism Spectrum Disorder Market?
Center-Based, In-Home, Others
What are the major end-use applications of Autism Spectrum Disorder Market?
SECONDARY RESEARCH Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.